Le Le Zhang
Fortuna: 4 M $ al 31/07/2026
Fortuna: 4 M $ al 31/07/2026
Le Le Zhang is the founder of Cutia Therapeutics, founded in 2019, holding the title of Chief Executive Officer & Executive Director since 2022.
The current job is General Manager & Director at Cutia Therapeutics (Shanghai) Co., Ltd. Education history includes a graduate degree from Shanghai Institute of Pharmaceutical Industry in 2005 and an undergraduate degree from Shenyang Pharmaceutical University in 2000.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CUTIA THERAPEUTICS 4,01 % | 03/11/2025 | 15.007.236 ( 4,01 % ) | 4 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CUTIA THERAPEUTICS | Fundador | 15/05/2019 |
Cutia Therapeutics (Shanghai) Co., Ltd.
Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics to severe facial acne vulgaris | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Shanghai Institute of Pharmaceutical Industry
Shanghai Institute of Pharmaceutical Industry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenyang Pharmaceutical University
Shenyang Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cutia Therapeutics (Shanghai) Co., Ltd.
Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics to severe facial acne vulgaris | Health Technology |
Cutia Therapeutics
Cutia Therapeutics Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing and marketing of dermatology based biopharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.